EUVIMEDEUVIMED entdecken
Fallbericht

Dosing impact of cefepime and meropenem on multidrug-resistant Pseudomonas aeruginosa chronic cellulitis: A case report

Xiaofeng Botner

Journal of the American Pharmacists Association · 2026

DOI: 10.1016/j.japh.2026.103017 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of the American Pharmacists Association, 2026. Verfasst von Xiaofeng Botner. Hauptthemen laut MEDLINE: Meropenem, Anti-Bacterial Agents, Cefepime, Pseudomonas aeruginosa. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: To describe a case of treatment failure and emergent resistance due to suboptimal antibiotic dosing and demonstrate a practical strategy for optimizing dosing to achieve treatment efficacy. CASE SUMMARY: We report a woman in her 90s with no history of renal disease but with low weight and height. She was treated with a renally adjusted dose of cefepime for cellulitis caused by multidrug resistant (MDR) Pseudomonas aeruginosa, with a minimum inhibitory concentration at the susceptibility borderline. One month later, she was re-admitted for cefepime-resistant P. aeruginosa cellulitis and therapy was switched to meropenem. The meropenem dose was optimized by evaluating both the creatinine clearance (CrCl) calculated by the Cockcroft-Gault equation and the modification of diet in renal disease (MDRD) estimated glomerular filtration rate (eGFR). This approach led to a successful treatment. PRACTICE IMPLICATIONS: This case highlights the challenge of dosing antibiotics in the elderly population for MDR bacteria, where high doses are often required. To prevent treatment failure and the emergence of resistance from suboptimal dosing, we recommend evaluating renal function using MDRD eGFR in addition to CrCl, when a significant discrepancy exists between the 2 values.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeropenemAnti-Bacterial AgentsCefepimePseudomonas aeruginosaPseudomonas InfectionsCellulitisHumansFemaleDrug Resistance, Multiple, BacterialAged, 80 and overGlomerular Filtration RateThird Generation CephalosporinsDose-Response Relationship, DrugMicrobial Sensitivity Tests

Substanzen

MeropenemAnti-Bacterial AgentsCefepimeThird Generation Cephalosporins

Zitieren

APA

Botner, X. (2026). Dosing impact of cefepime and meropenem on multidrug-resistant Pseudomonas aeruginosa chronic cellulitis: A case report. Journal of the American Pharmacists Association. https://doi.org/10.1016/j.japh.2026.103017

Vancouver

Botner X. Dosing impact of cefepime and meropenem on multidrug-resistant Pseudomonas aeruginosa chronic cellulitis: A case report. Journal of the American Pharmacists Association. 2026. doi:10.1016/j.japh.2026.103017

BibTeX
@article{Botner2026,
  author = {Botner, Xiaofeng},
  title = {Dosing impact of cefepime and meropenem on multidrug-resistant Pseudomonas aeruginosa chronic cellulitis: A case report},
  journal = {Journal of the American Pharmacists Association},
  year = {2026},
  doi = {10.1016/j.japh.2026.103017}
}
Kostenlos starten →